Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Epilepsia open. 2018 Dec 21. doi: 10.1002/epi4.12286. pii: EPI412286. pmc: PMC6398114
    Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study.
    Nabbout R1,  Belousova E2,  Benedik MP3,  Carter T4,  Cottin V5,  Curatolo P6,  Dahlin M7,  D Amato L8,  d'Augères GB9,  de Vries PJ10,  Ferreira JC11,  Feucht M12,  Fladrowski C13,  Hertzberg C14,  Jozwiak S15,  Lawson JA16,  Macaya A17,  Marques R18,  O'Callaghan F19,  Qin J20,  Sander V21,  Sauter M22,  Shah S23,  Takahashi Y24,  Touraine R25,  Youroukos S26,  Zonnenberg B27,  Jansen A28,  Kingswood JC29
    Collaborators
    Shinohara N Horie S Kubota M Tohyama J Imai K Kaneda M Kaneko H Uchida Y Endo S Inoue Y Uruno K Serdaroglu A Yapici Z Anlar B Altunbasak S Lvova O Valeryevich Belyaev O Agranovich O Vladislavovna Levitina E Vladimirovna Maksimova Y Karas A Jiang Y Zou L Xu K Zhang Y Luan G Zhang Y Wang Y Jin M Ye D Liao W Zhou L Liu J Liao J Yan B Deng Y Jiang L Liu Z Huang S Li H Kim K Chen PL Lee HF Tsai JD Chi CS Huang CC Riney K Yates D Kwan P Likasitwattanakul S Nabangchang C Thampratankul Krisnachai Chomtho L Katanyuwong K Sriudomkajorn S Wilmshurst J Segel R Gilboa T Tzadok M Fattal-Valevski A Papathanasopoulos P Syrigou Papavasiliou A Giannakodimos S Gatzonis S Pavlou E Tzoufi M Dhooghe M Verhelst H Roelens F Cecile Nassogne M Defresne P De Waele L Leroy P Demonceau N Van Bogaert P Ceulemans B Dom L Castelnau P De Saint Martin A Riquet A Milh M Cances C Pedespan JM Ville D Roubertie A Auvin S Berquin P Richelme C Allaire C Gueden S Nguyen The Tich S Godet B Rojas MLRF Planas JC Bermejo AM Dura PS Aparicio SR Gonzalez MJM Pison JL Blanco Barca MO Laso EL Luengo OA Rodriguez FJA Dieguez IM Salas AC Carrera IM Salcedo EM Petri MEY Candela RC Carrilho IDC Vieira JP Monteiro JPDSO Leao MJSOF Luis CSMR Pires Mendonca C Endziniene M Strautmanis J Talvik I Canevini MP Gambardella A Pruna D Buono S Fontana E Bernardina BD Burloiu C Cosma ISB Vintan MA Popescu L Zitterbart K Payerova J Bratsky L Zilinska Z Gruber-Sedlmayr U Haberlandt E Rostasy K Pataraia E Elmslie F Ann Johnston C Crawford P Uldall P Uvebrant P Rask O Bjoernvold M Sloerdahl A Solhoff R Jaatun MSG Mandera M Radzikowska EJ Wysocki M Fischereder M Kurlemann G Wilken B Wiemer-Kruel A Budde K Marquard K Knuf M Hahn A Hartmann H Merkenschlager A Trollmann R
    Author information
    1Department of Pediatric Neurology Necker Enfants Malades Hospital Paris Descartes University Paris France.
    2Research and Clinical Institute of Pediatrics Pirogov Russian National Research Medical University Moscow Russian Federation.
    3SPS Paediatric Clinic Ljubljana Slovenia.
    4TSA Tuberous Sclerosis Association Nottingham UK.
    5Hôpital Louis Pradel Claude Bernard University Lyon 1 Lyon France.
    6Tor Vergata University Hospital Rome Italy.
    7Karolinska University Hospital Stockholm Sweden.
    8Novartis Farma S.p.A. Origgio Italy.
    9Tuberous Sclerosis Association of Bourneville Gradignan France.
    10Division of Child and Adolescent Psychiatry University of Cape Town Cape Town South Africa.
    11Centro Hospitalar Lisboa Ocidental Lisbon Portugal.
    12Department of Pediatrics and Adolescent Medicine Medical University of Vienna Vienna Austria.
    13Tuberous Sclerosis Association ONLUS Milan Italy.
    14Vivantes Hospital Neukoelln Berlin Germany.
    15Department of Child Neurology Warsaw Medical University Warsaw Puerto Rico.
    16The Tuberous Sclerosis Multidisciplinary Management Clinic Sydney Children's Hospital Randwick NSW Australia.
    17Vall d'Hebron University Hospital Barcelona Spain.
    18Novartis Farma S.p.A. Origgio Italy.
    19Institute of Child Health University College London London UK.
    20Department of Pediatrics Peking University People's Hospital (PKUPH) Beijing China.
    21Tallinn Children Hospital Tallinn Estonia.
    22Clinic Group Kempten-Oberallgaeu GmbH Kempten Germany.
    23Novartis Healthcare Pvt. Ltd. Hyderabad India.
    24National Epilepsy Center Shizuoka Institute of Epilepsy and Neurological Disorders NHO Shizuoka Japan.
    25Department of Genetics CHU-Hôpital Nord Saint Etienne France.
    26St. Sophia Children's Hospital Athens Greece.
    27University Medical Center Utrecht The Netherlands.
    28Pediatric Neurology Unit Department of Pediatrics UZ Brussel VUB Brussels Belgium.
    29Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Centre St Georges University of London London UK.
    Abstract

    OBJECTIVE: To present the baseline data of the international TuberOus SClerosis registry to increase disease Awareness (TOSCA) with emphasis on the characteristics of epilepsies associated with tuberous sclerosis complex (TSC).

    METHODS: Retrospective and prospective patients' data on all aspects of TSC were collected from multiple countries worldwide. Epilepsy variables included seizure type, age at onset, type of treatment, and treatment outcomes and association with genotype, seizures control, and intellectual disability. As for noninterventional registries, the study protocol did not specify any particular clinical instruments, laboratory investigations, or intervention. Evaluations included those required for diagnosis and management following local best practice.

    RESULTS: Epilepsy was reported in 83.6% of patients (1852/2216) at baseline; 38.9% presented with infantile spasms and 67.5% with focal seizures. The mean age at diagnosis of infantile spasms was 0.4 year (median <1 year; range <1-30 years) and at diagnosis of focal seizures was 2.7 years (median 1 year; range <1-66 years). A total of 1469 patients (79.3%) were diagnosed with epilepsy <2 years. The rate of infantile spasms was higher in patients with a mutation than in patients with a  mutation (47.3% vs 23%). -aminobutyric acid (GABA)ergic drugs were the most common treatment modality for both infantile spasms (78.7%) and focal seizures (65.5%). Infantile spasms and focal seizures were controlled in 76.3% and 58.2% of patients, respectively. Control of seizures was associated with lower rates of intellectual disability in both groups.

    SIGNIFICANCE: This registry reports the largest international cohort of patients with TSC. Findings confirmed the typical onset pattern of infantile spasms and other focal seizures in the first 2 years of life, and the high rates of infantile spasms in patients with mutation. Our results underscored the occurrence of focal seizures at all ages, including an onset that preceded emergence of infantile spasms. Seizure control was shown to be associated with lower rates of intellectual disability but did not preclude the presence of intellectual disability.


    KEYWORDS: TOSCA, epilepsy, registry, tuberous sclerosis complex

    Publikations ID: 30868117
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt